POSAF
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
CIN rates POSaBIT Systems Neutral with conviction at two out of five, reflecting a composite near 46 points and an uneven pillar profile. Regulatory is the strongest contribution at 58, supported by an 80 jurisdiction-posture subscore and an 80 enforcement subscore. Fundamentals contribute 49, with exceptional gross-margin economics offset by contracting revenue, negative operating profitability, limited scale, and a stretched financial condition. Market contributes 40 because institutional pricing feeds carry no available quote, restricting price-based confirmation. Editorial contributes 30, consistent with no newsroom or brief activity in CIN newsroom coverage. The resulting band appropriately captures strong regulatory positioning without granting credit for operating momentum or market validation that the underlying data do not deliver.
Licensed fundamentals data show year-over-year revenue contraction of 25%, while gross margin remained unusually high at approximately 82.6%. That spread did not translate into operating profitability: operating margin was negative 10.3%, net income was a loss of roughly $1.16 million, and EBITDA was negative by about $1.15 million. The 69 operating-margin subscore and 54.3 cash-runway subscore offer partial fundamental support, but the zero market-cap tier subscore and 25 revenue-growth subscore constrain the pillar. A cash-burn ratio near 14.2% reinforces the stretched financial condition rather than indicating balance-sheet durability. Primary regulatory filings show no recorded events during either the past 90 or 180 days, no enforcement hits, and no available latest-filing date. That combination preserves the strong enforcement profile while holding the filing-cadence subscore at 25.
The clearest rerating catalyst sits within regulatory, the highest-scoring pillar. POSaBIT already benefits from favorable jurisdiction and enforcement readings, leaving filing cadence as the principal variable capable of broadening regulatory confidence. A timely primary regulatory filing that provides current operating and financial disclosure would strengthen transparency, sharpen interpretation of the revenue decline and negative margins, and create a firmer basis for institutional pricing feeds and CIN newsroom coverage. The single most important signal to watch is the re-establishment of a current, consistent primary regulatory filing cadence.
- IR / PR agency
- Hayden IR
- IR email
- investors@posabit.com
- IR page
- Investor relations
- CEO
- Ryan Hamlin
- CFO
- Stephen Gledhill
- SEC CIK
- 0001844459
- Website
- Company website
- Market cap
- $8.1M
- Enterprise value
- $8.4M
- Price to book
- 4.50
- Price to sales
- 0.87
- EV / EBITDA
- -17.46
- Revenue (TTM)
- $9.3M
- Gross profit (TTM)
- $7.7M
- EBITDA
- $-1.2M
- Operating margin
- -10.3%
- Profit margin
- -12.5%
- Rev growth YoY
- -25.0%
- Return on equity
- -540.2%
- Return on assets
- -11.7%
- Shares outstanding
- 162.2M
- Insider ownership
- 34.4%
- Beta
- 1.01
- Full-time employees
- 35
- GICS sector
- Technology
- GICS industry
- Software - Application
- Filing portal
- SEDAR+
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for POSAF (POSAF)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for POSAF (POSAF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for POSAF are maintained by Cannabis Investor News and refreshed throughout the trading day.